scholarly article | Q13442814 |
P50 | author | Marilza Campos-de-Magalhães | Q76322027 |
Soniza V Alves-Leon | Q88297048 | ||
Isabelle Vasconcellos de Souza | Q89678944 | ||
P2093 | author name string | Adilson José de Almeida | |
Fernando Raphael de Almeida Ferry | |||
Ana Carolina de Brito Lyra | |||
Juan Camilo Sánchez-Arcila | |||
Luiz Felipe Boufleur Long | |||
P2860 | cites work | Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | Q22242702 |
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy | Q26852180 | ||
Understanding frailty, aging, and inflammation in HIV infection | Q27021143 | ||
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients | Q27024262 | ||
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review | Q38237513 | ||
A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age. | Q38237514 | ||
Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy | Q38603237 | ||
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population | Q38851681 | ||
Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. | Q40215452 | ||
Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy | Q40367422 | ||
Biomarkers and Clinical Indices of Aging with HIV. | Q40440334 | ||
Therapeutic advances: protease inhibitors for the treatment of HIV-1 infection | Q40898009 | ||
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study | Q41067770 | ||
Elevated ischemic stroke risk among women living with HIV infection | Q41996527 | ||
Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. | Q42197898 | ||
HIV is associated with thrombophilia and high D-dimer in children and adolescents. | Q43157187 | ||
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy | Q43237794 | ||
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. | Q44492237 | ||
Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria | Q45227470 | ||
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection | Q45729086 | ||
Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. | Q45729419 | ||
Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy. | Q46431385 | ||
Anti-viral activity of human antithrombin III. | Q46597118 | ||
HIV and the menopause: A review. | Q47292815 | ||
Geriatric-HIV medicine: A science in its infancy | Q48352423 | ||
Ageing and inflammation in patients with HIV infection. | Q30244296 | ||
Hemostasis factors and aging | Q33299066 | ||
Effects of first-line anti-retroviral therapy on blood coagulation parameters of HIV-infected patients attending a tertiary hospital at Abuja, Nigeria | Q33434893 | ||
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease | Q33528999 | ||
HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging | Q33583519 | ||
Is HIV a model of accelerated or accentuated aging? | Q33792651 | ||
Correlates of D-dimer in older persons | Q33825375 | ||
Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication | Q33886860 | ||
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation | Q34288534 | ||
Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries | Q34332446 | ||
Chronic HIV disease and activation of the coagulation system | Q34342368 | ||
In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes | Q34469655 | ||
Antithrombin: a new look at the actions of a serine protease inhibitor | Q35004303 | ||
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation | Q35021902 | ||
HIV infection in the elderly | Q35086332 | ||
Association of antiretroviral therapy with fibrinogen levels in HIV-infection | Q35166181 | ||
HIV status and the risk of ischemic stroke among men. | Q35611619 | ||
Management of protease inhibitor-associated hyperlipidemia | Q35631233 | ||
HIV infection is associated with decreased thrombin generation | Q35845337 | ||
Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores | Q35862321 | ||
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy | Q36015621 | ||
Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis | Q36250909 | ||
Hemostasis and aging | Q36543985 | ||
Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis | Q36602044 | ||
Early immune senescence in HIV disease | Q37084912 | ||
Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status | Q37102595 | ||
Cytomegalovirus and human immunosenescence | Q37335339 | ||
Premature aging of T cells is associated with faster HIV-1 disease progression | Q37399302 | ||
Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV. | Q37556442 | ||
The hemostatic system through aging and menopause. | Q37610388 | ||
Menopause and aging: changes in the immune system--a review. | Q37784916 | ||
Human immunodeficiency virus and menopause | Q38093357 | ||
Biologic aging, frailty, and age-related disease in chronic HIV infection | Q38212714 | ||
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV. | Q38226374 | ||
Cognitive impairment among older adults living with HIV/AIDS and frailty. | Q51787081 | ||
Elevated fibrinogen causes thrombosis. | Q52845746 | ||
Fibrinogen and Fibrin in Hemostasis and Thrombosis. | Q54842287 | ||
Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study. | Q55310223 | ||
Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV | Q56837870 | ||
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units | Q56972703 | ||
Metabolic syndrome in human immunodeficiency virus-infected patients | Q59359662 | ||
Age-related changes in the hemostatic system | Q70668496 | ||
Fibrin Degeneration Product Concentrations (D-Dimers) in the Course of Ageing | Q71846271 | ||
Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers) | Q72021999 | ||
Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q72600744 | ||
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy | Q74225980 | ||
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age? | Q80048925 | ||
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study | Q80048927 | ||
Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection | Q81199933 | ||
HIV in the elderly: an emergent challenge | Q84058700 | ||
Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population | Q85389008 | ||
HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations | Q91617762 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P304 | page(s) | e0227763 | |
P577 | publication date | 2020-02-12 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study | |
P478 | volume | 15 |
Q90356617 | Correction: Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study | cites work | P2860 |
Search more.